GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Other Income (Expense)

Theratechnologies (Theratechnologies) Other Income (Expense) : $0.72 Mil (TTM As of Feb. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Other Income (Expense)?

Theratechnologies's other income expense for the Theratechnologies's pretax income for the three months ended in Feb. 2024 was $0.21 Mil. Its other income expense for the trailing twelve months (TTM) ended in Feb. 2024 was $0.72 Mil.

Theratechnologies Other Income (Expense) Historical Data

The historical data trend for Theratechnologies's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Other Income (Expense) Chart

Theratechnologies Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 0.41 -0.93 -0.67 -2.32

Theratechnologies Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.83 0.34 1.91 -1.74 0.21

Theratechnologies Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theratechnologies  (NAS:THTX) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Theratechnologies (Theratechnologies) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Other Income (Expense)
Comparable Companies
TSX:SVA TSXV:MIR XCNQ:METX TSXV:ARCH XCNQ:DTC TSX:MSCL TSX:ONC XCNQ:ACOG TSX:HBP TSX:MBX OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
TQ80:Germany TH:Canada
Address
2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8
Website
https://www.theratech.com
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.